Market revenue in 2023 | USD 340.7 million |
Market revenue in 2030 | USD 177.2 million |
Growth rate | -8.9% (CAGR from 2023 to 2030) |
Largest segment | Quantitative |
Fastest growing segment | Digital |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Quantitative, Digital, End-point |
Key market players worldwide | Abbott Laboratories, Qiagen NV, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, GE Aerospace, BioMerieux SA, Roche Holding AG ADR, Fluidigm Corporation |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to real time pcr, digital pcr, and end point pcr market will help companies and investors design strategic landscapes.
Quantitative was the largest segment with a revenue share of 90.08% in 2023. Horizon Databook has segmented the India real time pcr, digital pcr, and end point pcr market based on quantitative, digital, end-point covering the revenue growth of each sub-segment from 2018 to 2030.
Cardiovascular diseases are the primary cause of mortality in India. According to a Global Burden of Disease study published in 2022, India has a higher cardiovascular disease death rate than the global average.
Around 349 per 100,000 people are diagnosed with some form of cardiovascular disorder in India. Moreover, the prevalence of infectious diseases is expected to increase the demand for PCR tests.
Rapid economic development in the nation has dramatically increased purchasing capacity, propelling the demand in the market. In February 2023, the Ministry of Health and Family Welfare’s decision to ease guidelines for international passengers, stating that individuals from certain countries would not require COVID-19 tests upon arrival in India, marked a significant shift in travel protocols.
Horizon Databook provides a detailed overview of country-level data and insights on the India real time pcr, digital pcr, and end point pcr market , including forecasts for subscribers. This country databook contains high-level insights into India real time pcr, digital pcr, and end point pcr market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account